Christopher E. Brightling

Christopher E. Brightling

University Road
Leicester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 301 publications

Tozorakimab to Prevent COPD Exacerbations.

Tozorakimab to Prevent COPD Exacerbations.

Journal: The New England journal of medicine

Published: September 08, 2026

Astegolimab for chronic obstructive pulmonary disease with frequent exacerbations: pooled analysis of the ALIENTO and ARNASA trials.

Astegolimab for chronic obstructive pulmonary disease with frequent exacerbations: pooled analysis of the ALIENTO and ARNASA trials.

Journal: American journal of respiratory and critical care medicine

Published: April 02, 2026

The impact of benralizumab and dupilumab on exhaled volatile organic compound profiles of severe asthma patients - a preliminary analysis.

The impact of benralizumab and dupilumab on exhaled volatile organic compound profiles of severe asthma patients - a preliminary analysis.

Journal: Respiratory medicine

Published: March 23, 2026

Reply to Zhao et al.: Clarifying structural-functional coupling by FeNO status in VESTIGE.

Reply to Zhao et al.: Clarifying structural-functional coupling by FeNO status in VESTIGE.

Journal: American journal of respiratory and critical care medicine

Published: March 12, 2026

Reply to Zhao et al.: Clarifying Structural - Functional Coupling by FeNO Status in VESTIGE.

Reply to Zhao et al.: Clarifying Structural - Functional Coupling by FeNO Status in VESTIGE.

Journal: American journal of respiratory and critical care medicine

Published: March 12, 2026

Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studies.

Symptom burden to characterise, predict, and prevent asthma attacks: a patient-level meta-analysis of randomised trials and translational prospective studies.

Journal: The Lancet. Respiratory medicine

Published: March 02, 2026

Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials.

Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials.

Journal: Lancet (London, England)

Published: March 02, 2026

Genome-wide association study of asthma with high treatment burden and/or worse outcomes defined using electronic healthcare data in UK Biobank.

Genome-wide association study of asthma with high treatment burden and/or worse outcomes defined using electronic healthcare data in UK Biobank.

Journal: ERJ open research

Published: February 27, 2026

Investigating prognostic classifications of preexisting multiple long-term conditions for health outcomes 1 year after COVID-19 hospitalization: A UK prospective observational study.

Investigating prognostic classifications of preexisting multiple long-term conditions for health outcomes 1 year after COVID-19 hospitalization: A UK prospective observational study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 16, 2025

Investigating prognostic classifications of pre-existing multiple long-term conditions for health outcomes one-year after COVID-19 hospitalisation: a UK prospective observational study.

Investigating prognostic classifications of pre-existing multiple long-term conditions for health outcomes one-year after COVID-19 hospitalisation: a UK prospective observational study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 16, 2025

Clinical phenotyping of asthma patients with elevated sputum eosinophils and low blood eosinophils: a post-hoc analysis of the multicentre ATLANTIS cohort.

Clinical phenotyping of asthma patients with elevated sputum eosinophils and low blood eosinophils: a post-hoc analysis of the multicentre ATLANTIS cohort.

Journal: EBioMedicine

Published: November 28, 2025

Consortium-Based Patient and Public Involvement and Engagement for Long COVID Research: A Pirit-Focused Impact Evaluation of the PHOSP-COVID Study.

Consortium-Based Patient and Public Involvement and Engagement for Long COVID Research: A Pirit-Focused Impact Evaluation of the PHOSP-COVID Study.

Journal: Health expectations : an international journal of public participation in health care and health policy

Published: November 18, 2025

Showing 1-12 of 301

Last Updated: 09/26/2026